Article

Engineering mesenchymal stem cells with neutralizing and anti- inflammation dual-capability against SARS-CoV-2 infection

2020-06-02

Abstract excerpt

The emergence of the novel human coronavirus SARS-CoV-2 has caused a worldwide epidemic of coronavirus disease 2019 (COVID-19), which markedly affected the global health and economy. Both uncontrolled viral replication and proinflammatory cytokine storm can cause severe tissue damage in COVID-19 patients. SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) as its entry receptor. In this study, we generated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1da7a4de-2baf-506d-a5bf-b5500bf898f0
DOI: 10.21203/rs.3.rs-32959/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Engineering mesenchymal stem cells with neutralizing and anti- inflammation dual-capability against SARS-CoV-2 infectionDOI 10.21203/rs.3.rs-32959/v1Read

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based TherapySemantic proximity Read

Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2Semantic proximity Read

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospectsSemantic proximity Read

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathologySemantic proximity Read

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activitiesSemantic proximity Read

The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responsesSemantic proximity Read

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Semantic proximity Read

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity Read

ACE2 is the critical <i>in vivo</i> receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathologySemantic proximity Read

Mesenchymal Stem Cells Impact on COVID-19 Patients Immune System, an Ex Vivo StudySemantic proximity Read